Answers are grounded in this paper and cite their sources.
Simulation study reveals required sample sizes for chronic wasting disease surveillance in deer populations, indicating that detecting low prevalence requires large hunter-harvest testing quotas.
Managing chronic wasting disease (CWD) – a fatal, transmissible prion disease of cervids – has many challenges, such as determining the number of cervids to test to accurately estimate true prevalence with apparent prevalence. Options range from basic equations to complex techniques like agent-based modelling, but the former does not account for parameter uncertainty, and more detailed models may be less accessible for managers. Our study used Monte Carlo simulation to create a reference table showing the number of hunter-harvested deer to test to approximate herd true prevalence with a ± 2% margin of error and 95% confidence. A three-step process was simulated in which deer from the total population were harvested (testable subpopulation), and then a subset of those harvested deer were tested for CWD (tested group) with diagnostic testing error, with group assignment determined by random sampling. We evaluated true prevalences ranging from 0.5–20% and testable subpopulation sizes up to 5,000 deer from a total population of 20,000. An example from the reference table shows that detecting a 1% true prevalence in a testable subpopulation of 300 deer requires testing ≥280 deer, and that the only way to accurately detect a true prevalence of 0.5% is to test 600 out of 5,000 deer. Evaluating IDNR’s CWD surveillance efforts found that 16.14% of counties had adequate sample sizes in a given year and could detect true prevalences as low as 1%, showing that these guidelines are achievable.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: